# OnCo record azd0486 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/azd0486/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "azd0486" ;
  schema:name "AZD0486"@en ;
  schema:description "AZD0486 is an experimental bispecific antibody from AstraZeneca in phase 3 trials for diffuse large B-cell lymphoma, aimed at CD19 and CD3."@en ;
  schema:url <https://onco.cc/drugs/azd0486/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=TNB-486> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "bispecific antibody" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:trials <https://onco.cc/trials/nct07215585/>, <https://onco.cc/trials/nct06549595/>, <https://onco.cc/trials/nct07509151/>, <https://onco.cc/trials/nct06526793/>, <https://onco.cc/trials/nct06564038/> .